 MINNEAPOLIS, Sept. 07, 2021 GLOBE NEWSWIRE -- Panbela Therapeutics, Inc. Nasdaq: PBLA, a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced that it will present at upcoming investor conferences: 